Found 205 matching trials
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
PHASE1This phase I trial studies the side effects and best dose of selinexor when...
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies
PHASE2The primary trial objective is to determine the efficacy of KPT-330 (seline...
Location
UZ Leuven - Universitair Ziekenhuis Leuven
Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation
PHASE2This is a multi-center, phase 2, single arm, open-label study of oral selin...
Location
University of Arizona Cancer Center
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
PHASE1This is an open label, multicenter, dose escalation, phase Ib study to dete...
Location
Institut Jules Bordet
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
PHASE1This is a single arm, open-label, phase I dose finding study, followed by a...
Location
National University Hospital
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
N/AThis is a retrospective observational study of the therapeutic mechanism an...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Selinexor, Cyclophosphamide and Prednisone in Myeloma
PHASE2The trial is designed as a randomised, controlled, open, parallel group, mu...
Location
Birmingham Heartlands Hospital
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
PHASE2This is a prospective, single-arm, open-label clinical study to evaluate th...
Status
Active Not Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
PHASE1The main purpose of this study is to determine the recommended doses of sel...
Location
H. Lee Moffitt Cancer Center and Research Institute